Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Ordinary Shares without par value
-
Shares outstanding
-
292,938,399
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
16,003,620
-
Shares change
-
-519,866
-
Total reported value, excl. options
-
$773,467,989
-
Value change
-
-$22,236,435
-
Number of buys
-
83
-
Number of sells
-
-68
-
Price
-
$48.33
Significant Holders of Fresenius Medical Care AG - Ordinary Shares without par value (FMS) as of Q2 2017
205 filings reported holding FMS - Fresenius Medical Care AG - Ordinary Shares without par value as of Q2 2017.
Fresenius Medical Care AG - Ordinary Shares without par value (FMS) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,003,620 shares
of 292,938,399 outstanding shares and own 5.5% of the company stock.
Largest 10 shareholders include HARDING LOEVNER LP (3,748,173 shares), CAMBIAR INVESTORS LLC (2,596,480 shares), BANK OF AMERICA CORP /DE/ (1,413,601 shares), NORTHERN TRUST CORP (932,246 shares), MORGAN STANLEY (701,833 shares), MARATHON ASSET MANAGEMENT LLP (626,846 shares), ROYAL BANK OF CANADA (501,682 shares), US BANCORP \DE\ (427,021 shares), Parametric Portfolio Associates LLC (396,119 shares), and Jarislowsky, Fraser Ltd (291,315 shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.